X

Stay Connected

Sign Up for Updates

We are creating a place where we can share ideas, provide the perspective of America's biopharmaceutical companies and, most importantly, listen to you.

West Virginia becomes the first state to lower patient costs by sharing the savings

By Scott LaGanga  |    April 20, 2021
In a historic moment for patient affordability, last week West Virginia became the first state in the nation to adopt ground-breaking legislation, HB2263, requiring insurers and their PBMs to...   Read More

What they are saying: Experts highlight the importance of IP in recent NIST proposal comments

By Megan Van Etten  |    April 20, 2021
Strong, reliable, and clearly defined intellectual property (IP) protections are the foundation of America’s robust innovation ecosystem that patients across the globe rely on for the research and...   Read More

PhRMA member companies share how they are improving clinical trial diversity

By Dr. Freda Lewis-Hall  |    April 14, 2021
As part of the biopharmaceutical industry’s efforts to improve health outcomes for patients in underserved communities, PhRMA member companies are identifying ways to improve clinical trial...   Read More

Our three-part approach to build a better health care system

By Stephen J. Ubl  |    April 13, 2021
On April 3, more than four million Americans received a COVID-19 vaccine — the largest single-day vaccination event in human history. For innovators across the pharmaceutical industry, these...   Read More

ICYMI: New CBO Report highlights biopharmaceutical leadership in the development of new treatments and cures

By Andrew Powaleny  |    April 12, 2021
America’s biopharmaceutical companies are at the heart of a research and development (R&D) ecosystem that develops more innovative medicines than any other country in the world. The ongoing...   Read More

Diversifying clinical trials and fighting disease requires equity and trust

By Rebecca Marklund  |    April 12, 2021
The COVID-19 pandemic has left no person unaffected, but Black Americans have been disproportionately impacted. Black adults are nearly four times more likely to be hospitalized from the virus and...   Read More

Key excerpts: PhRMA submits comments to NIST in effort to safeguard intellectual property protections

By Megan Van Etten  |    April 9, 2021
Earlier this week PhRMA submitted comments to the National Institute of Standards and Technology (NIST) regarding the proposed rulemaking on implementing regulations of the Bayh-Dole Act. Passed...   Read More

Strengthening a culture dedicated to patients and equity: A conversation with Vas Narasimhan, CEO of Novartis

By Stephen J. Ubl  |    March 31, 2021
This year our industry has been working around the clock to combat the COVID-19 virus, including developing effective therapeutics to treat COVID-19 and vaccines to prevent future infections....   Read More

Data shows that keeping a strong biopharmaceutical industry is important to Americans

By Mark Keida  |    March 30, 2021
The United States biopharmaceutical industry continues to innovate and discover critical solutions for our toughest health challenges such as the COVID-19 pandemic. America’s global leadership has...   Read More

New report demonstrates the growing importance of partnerships in advancing biomedical innovation

By Abigail Lore  |    March 24, 2021
As we mark a full year since COVID-19 was declared a global pandemic, it’s impossible to overstate the significance of collaborations. The unprecedented level of strategic collaborative efforts...   Read More

Search the Catalyst

View Posts by Topic

see all

View Posts by Date

see all

Subscribe to Email Updates